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Abstract
Background—Late life depression, including patients with vascular depression, has been
associated with higher levels of intima-media thickness (IMT). Although individuals with vascular
depression tend to report a later onset of depression, the relationship of IMT and age of first depressive
episode is uncertain in younger adults. We therefore investigated the relationship between IMT and
age of first depressive episode in a sample of 202 adults (age range 40−81 years) with major
depression (MDD).
Methods—Depression status was assessed using the Structured Clinical Interview Schedule and
the Hamilton Depression Rating Scale. Patients underwent a physical examination in which a medical
history was obtained. IMT was measured from the left and right common carotid arteries. Simple
regression analyses were used to investigate the association between IMT and self-reported age of
first depressive episode.
Results—IMT was associated with a later onset of first major depressive episode (b = .225, P = .
0005) and this association remained significant after controlling for age, Framingham Stroke Risk
Profile, smoking pack years, physical activity, high- and low-density lipoprotein, body mass index,
triglyceride levels, and history of chronic medical conditions (b = .142, P = .028). Each .10 mm
increase in IMT was associated with a 2.6-year later reported occurrence of first major depressive
episode (MDE). Similarly, higher levels of IMT were associated with fewer previous MDEs (b = −.
149, P = .020) and this effect remained significant in our multivariate model (b = −.140, P = .030).
In contrast, IMT was not associated with current depressive severity (b = −.024, P = .720).
Conclusions—Greater levels of IMT are associated with a later onset of depression and fewer
previous depressive episodes among middle-aged and older adults, independent of cardiovascular
co-morbidities. These findings provide preliminary evidence that increased vascular burden may be
associated with a later onset of depression.
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1. Introduction
Major depression (MDD) is one of the primary causes of disability in the United States (Simon,
2003) and is associated with significant cardiovascular morbidity (Barnes et al., 2006).
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Individuals experiencing MDD in later life exhibit a greater prevalence of vascular
depression (Mast et al., 2008), characterized by poorer vascular health, cognitive decrements,
and a later onset of first depressive episode, typically occurring after age 50 (Kim et al.,
2006). Recent studies have demonstrated that individuals with a later onset of first MDE exhibit
greater intima-media thickness (IMT), a marker of systemic atherosclerosis, compared with
controls (Chen et al., 2006).
Despite evidence that individuals with vascular depression exhibit a later onset of first
depressive episode and greater vascular burden, the mechanisms responsible for the
characteristic later onset of this disorder have received little attention. It has been hypothesized
that poorer vascular health results in greater white matter damage, resulting in dysregulation
of the frontal-striatal systems of the brain (Alexopoulos et al., 2008), which are critical for
modulation of affect (Gunning-Dixon et al., 2008; Davidson et al., 2002). Although a
relationship between poorer vascular health and white matter damage has been demonstrated
in healthy adults (Jeerakathil et al., 2004; Herrmann et al., 2008) and individuals with MDD
(Chen et al., 2006), to our knowledge, the relationship between vascular health and age of first
MDE has not been studied. We therefore investigated the relationship between IMT and age
of first MDE among 202 middle-aged and older adults with MDD.
2. Methods
2.1. Study design
The sample examined in this report represents baseline data obtained from a subset of
individuals from a larger clinical trial of exercise and medication among middle-aged and older
adults with MDD (Blumenthal et al., 2007). Exclusion criteria included a primary psychiatric
diagnosis other than MDD, medical contraindications preventing participation in either the
exercise or medication arm of the larger study (i.e., sertraline), and current treatment for MDD.
No patient was on an anti-depressant at the time of this assessment. Participants were recruited
from October 2000 to September 2005 and the study protocol was approved by a Duke
Institutional Review Board.
2.2. Cerebrovascular risk factors
2.2.1. Framingham stroke risk profile—A modified version of the Framingham Stroke
Risk Profile (FSRP), a risk assessment tool used to assess the risk of incident stroke, was used
an index of cerebrovascular risk (Dagostino et al., 1994). Risk factors used to assess stroke
risk include systolic blood pressure, use of antihypertensive therapy, diabetes mellitus,
cigarette smoking, cardiovascular disease, and atrial fibrillation (Dagostino et al., 1994).
Details of our cerebrovascular risk factor and IMT assessments have been previously reported
(Smith et al., 2007). Because age served as a covariate in our statistical analyses, it was not
included in calculating Framingham Stroke Risk Profile scores. Furthermore, left ventricular
hypertrophy, a component of the original Framingham Stroke Risk Profile score, was not used
in the current analysis because this information was not obtained for any participant.
2.2.2. Serum cholesterol—High-density lipoprotein (HDL-C) and low-density lipoprotein
(LDL-C) cholesterol were assessed enzymatically (LabCorp, Research Triangle Park, NC).
HDL-C was estimated by assay of the supernatant remaining after precipitation of serum LDL
with dextran sulfate plus magnesium chloride. Participants fasted for 12 h prior to this
assessment.
2.3. Measures of vascular health
2.3.1. Intima-media thickness (IMT) in carotid arteries—Carotid artery IMT was
assessed by high-resolution B-mode ultrasound using an Acuson Aspen (Mountain View, CA)
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vascular imaging system with 10 MHz linear array transducer. Ultrasound examinations of the
far wall of the left and right common carotid arteries were used to acquire longitudinal images
spanning 2 cm proximal to the carotid bulb. IMT of the far wall of the left and right common
carotid arteries was measured over a 1 cm segment using Carotid Analyzer 5.0.5 (Medical
Imaging Applications LLC, Iowa City, IA) edge detection software. Far wall measurements
only were utilized as near wall measurements have been shown to have limited reliability
(Wendelhag et al., 1991). Because left and right-sided IMT values were similar (mean left-
sided IMT = .63 mm, SD = .15 mm; mean right-sided IMT = .63 mm, SD = .15 mm) and
substantially intercorrelated (r = .57, P < .0001), these values were averaged to create one IMT
value for each participant.
2.4. Assessment of depression
2.4.1. Structured clinical interview for the DSM-IV—The presence of MDD was
determined by a trained clinical psychologist using the Structured Clinical Interview for the
DSM-IV (SCID) (American Psychiatric Association, 2004). All participants met criteria for
MDD based on Diagnostic and Statistical Manual-IV (American Psychiatric Association,
2004).
2.4.2. Hamilton rating scale for depression—Depression severity was assessed using
the Hamilton Rating Scale for Depression (HRSD) (Williams, 1988), a 17-item clinical rating
scale that assesses the severity of depressive symptoms such as changes in appetite, sleep, and
depressed mood.
2.4.3. Age of onset of first MDE and number of previous MDEs—The SCID was
supplemented with additional questions pertaining to the onset and treatment of the current
MDE, as well as any prior MDEs. Previous MDEs were indexed as 0, 1, 2, or ≥ 3 MDEs prior
to the current episode.
2.5. Statistical analysis
2.5.1. Data analysis—In order to determine the relationship between IMT, reported age of
first MDE, and number of previous depressive episodes, we first examined the bivariate
correlations between IMT and our depression variables. We then constructed two regression
models in order to examine these relationships while controlling for relevant cardiovascular
co-morbidities. In order to control for the effects of age in our analysis, IMT was examined as
a dependent variable. Within these models, age at first MDE and number of previous MDEs
were our predictors of interest while current age and cardiovascular co-morbidities served as
covariates. Cardiovascular co-morbidities included the Framingham Stroke Risk Profile,
current and previous smoking packs-per-year (PPY), physical activity (GODIN) (Godin and
Shephard, 1985), body-mass index (BMI), HDL and LDL cholesterol, triglycerides, and history
of chronic disease (e.g., stroke, cancer, and/or arthritis). As a supplementary analysis, we
examined the association between IMT and depression severity, indexed by the HRSD. In this
model, HRSD scores served as the predictor of interest with IMT as the dependent variable,
controlling for cardiovascular co-morbidities. Multiple imputation based on the parametric
maximum likelihood regression was used to account for missing data. Missing data was
minimal (Harrell, 2001), with only 7 individuals (3.5%) missing IMT data and 5 (2.5%) missing
data on age of first depressive episode. Model assumptions of additivity, linearity, and
distribution of residuals were evaluated and found to be adequate before analysis.
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Participants ranged in age from 40 to 81 years of age (mean age = 51.7 years, SD = 7.6). As
shown in Table 1, the majority of participants were female (75.7%) and Caucasian (67.8%),
and almost half were college-educated (49.5%). Participants were in generally good health, as
indexed by relatively low levels of FSRP (mean FSRP = 5.39, SD = 3.2), SBP (mean SBP =
124.2 mmHg, SD = 17.4), LDL cholesterol (mean LDL = 122.5 mg/dL, SD = 32.9), IMT (mean
IMT = 0.63 mm, SD = .13), and higher HDL cholesterol (mean HDL = 56.9 mg/dL, SD =
16.0). The sample was relatively free of other co-morbidities such as diabetes (6.9%), arthritis
(21.8%), current tobacco use (15.8%), history of cancer (5.5%), and history of stroke (2%).
3.2. Relationship of IMT, age of first MDE, and number of previous MDEs
In an unadjusted bivariate analysis, higher levels of IMT were associated with later ages of
first MDE (b = .225, P = .0005) (Fig. 1). Every .10 mm increase in IMT was associated with
an approximate 2.6 year later reported first MDE. As shown in Table 2, this relationship was
only slightly attenuated when age, Framingham Stroke Risk Profile, BMI, HDL, LDL,
triglycerides, history of chronic medical conditions, smoking history, and physical activity
were controlled (b = .142, P = .028). Similarly, higher levels of IMT were associated with
fewer previous MDEs (b = −.149, P = .020) and this effect remained significant in our
multivariate model (b = −.140, P = .030). In contrast, IMT was not associated with depression
severity (b = −.024, P = .720) and this effect was unchanged after controlling for cardiovascular
co-morbidities.
4. Discussion
Results from the present analysis demonstrate that higher levels of IMT are associated with a
later onset of first depressive episode and fewer previous depressive episodes, independent of
cardiovascular co-morbidities. In contrast, IMT was unrelated to the severity of current
depressive symptomatology. Our findings are consistent with previous observations in older
patients demonstrating that elevated IMT is present in individuals with late-onset depression
(Kim et al., 2006). Moreover, our findings are consistent with the notion that subclinical
vascular disease may be associated with a later onset of MDD.
Our finding that higher levels of IMT may be associated with late-onset of depression is
consistent with previous observations that elevated IMT is present in individuals with late-
onset MDD (Kim et al., 2006). Greater IMT has been frequently observed among individuals
with late-onset MDD (Kim et al., 2006; Campbell and Coffey, 2001) and is associated with
increasing levels of white matter damage in this population (Chen et al., 2006). Moreover,
recent work suggests that cerebral white matter damage, which often results from
atherosclerosis, may independently predict the development of depressive symptoms
(Teodorczuk et al., 2007)(Herrmann et al., 2008). Taken together, these findings are consistent
with the hypothesis that cerebrovascular disease may be associated with an increased risk of
incident depression among adults (Taylor et al., 2006; Alexopoulos, 2006; Alexopoulos et al.,
1997).
The relationship between depression and subclinical vascular disease is complex and most
likely results from overlapping pathogenic processes. In contrast to the typical clinical
presentation of MDD, individuals with vascular depression exhibit greater cardiovascular risk
factors, cognitive decrements, a later age of onset, and are less likely to report a family history
of depression (Alexopoulos et al., 1997). Although subclinical vascular disease appears to
precede depressive symptoms among individuals with vascular depression, depressive
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symptoms in younger adults have been shown to predate vascular changes in some cases
(Stewart et al., 2007). It is therefore possible that the observed relationship between greater
IMT and late age of first MDE may have resulted from either pathophysiologic changes
associated with atherosclerosis (Bruce and Musselman, 2005; Sherwood et al., 2005) or from
patients chronically engaging in poor health behaviors. For example, previous studies have
shown that greater psychosocial stress may be associated with poorer lifestyle choices (e.g.,
cigarette smoking, physical inactivity) (Green and Pope, 2000), which are associated with
increased levels of IMT (Jeerakathil et al., 2004). However, the prevalence of smoking was
relatively low in this study (16%) (Smith et al., 2007) and baseline physical activity level did
not correlate with baseline depression severity in this sample.
This preliminary report has several limitations. Because our assessment of age at first MDE
was based upon self-report, and was not corroborated by a third party, it is possible that patients
were inaccurate in their recall of previous events. Second, with the exception of blood pressure
and cholesterol measures, cerebrovascular risk factors also were based upon self-report and it
is therefore possible that individuals with occult coronary disease might have gone undetected.
Finally, because participants in the current study were volunteers and generally in good health,
it is difficult to determine the generalizability of our findings to other outpatients with MDD
(Zimmerman et al., 2002).
In summary, higher levels of IMT were associated with a later onset of first MDE and fewer
previous depressive episodes among middle-aged and older adults with MDD. Future studies
should investigate the prospective association between subclinical vascular disease, cerebral
white matter damage, and MDD status to confirm this observation and elucidate the temporal
relationship between these factors.
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Intima-media thickness and age of first MDE. Higher IMT was associated with a later onset
of first MDE (b = .225, P = .0005).
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Age (year) 51.6 7.5
Gender (male), n (%) 48 (24)
Caucasians, n (%) 134 (68)
Education (college graduate), n (%) 100 (51)
HRSD 17 4.3
Married, n (%) 75 49
IMT (mm) 0.63 0.13
Current smoker, n (%) 32 (16)
Previous smoker (excluding current use), n (%) 65 (38)
SBP (mmHg) 124 18
DBP (mmHg) 79 10
BP-lowering medications, n (%) 47 (23)
Total cholesterol (mg/dL) 207 41
LDL total (mg/dL) 122 33
HDL total (mg/dL) 56.9 15.8
Lipid-lowering medications, n (%) 17 (8)
BMI (kg/m2) 30.1 7.1
GODIN Exercise 9.5 10.3
Framingham Risk Profile Score 5.4 3.2
Age of first depressive episode (year) 38.3 13.6
Previous depressive episodes, n (%)
    (0) 69 (34.2)
    (1) 48 (23.8)
    (2) 15 (7.4)
    (≥3) 70 (34.7)
Note: HRSD indicates Hamilton rating scale for depression; IMT indicates intima-medial thickness; SBP indicates systolic blood pressure; DBP indicates
diastolic blood pressure; mmHg indicates millimeters of mercury; LDL indicated low-density lipoprotein; HDL indicates high-density lipoprotein; BMI
indicated body mass index.
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Table 2
Results of linear regression model predicting IMT.
Variable (interquartile range) b P-value
Age (10) .177 .006
FSRP (2) .078 .224
Smoking, PPY (364) .048 .470
GODIN (15) .079 .249
HDL (22) −.114 .076
LDL (43) −.064 .328
BMI (9.3) .228 <.001
Triglycerides (101) −.046 .476
Chronic co-morbidities (Y) .058 .368
Age at First MDD (19) .142 .028
*Note: Continuous predictors were rescaled by dividing the raw unscaled value by the interquartile range of the predictor. The scaling factor is shown in
the parentheses to the right of the name of the predictor in column 1. For example, the regression coefficient for age represents the expected change in
IMT for every 10-year increase in age. An alternative interpretation of is that it compares a “typical” person in the middle of the upper half of the predictor
distribution with a “typical” person in the middle of the lower half of the predictor distribution. FSRP = Framingham Stroke Risk Profile; GODIN = Godin
Leisure-Time Exercise. Chronic co-morbidities = stroke, cancer, and arthritis.
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